278 related articles for article (PubMed ID: 37735815)
21. Transcriptome and Regulatory Network Analyses of CD19-CAR-T Immunotherapy for B-ALL.
Zhang Q; Hu H; Chen SY; Liu CJ; Hu FF; Yu J; Wu Y; Guo AY
Genomics Proteomics Bioinformatics; 2019 Apr; 17(2):190-200. PubMed ID: 31201998
[TBL] [Abstract][Full Text] [Related]
22. miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.
Świtlik W; Karbownik MS; Suwalski M; Kozak J; Szemraj J
Cancer Biomark; 2018 Feb; 21(2):479-488. PubMed ID: 29103030
[TBL] [Abstract][Full Text] [Related]
23. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.
Kosti P; Maher J; Arnold JN
Front Immunol; 2018; 9():1104. PubMed ID: 29872437
[TBL] [Abstract][Full Text] [Related]
24. Small non-coding RNA sequencing reveals global dysregulation of piwi-interacting RNA (piRNA) expression in gonadal malignant germ cell tumours.
Laidlaw S; Alonso-Crisostomo L; Bailey S; Saini HK; Molnár A; Nicholson JC; Enright AJ; Scarpini CG; Rahbari R; Coleman N; Murray MJ;
Andrology; 2023 May; 11(4):738-755. PubMed ID: 36254403
[TBL] [Abstract][Full Text] [Related]
25. Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.
Li D; Li N; Zhang YF; Fu H; Feng M; Schneider D; Su L; Wu X; Zhou J; Mackay S; Kramer J; Duan Z; Yang H; Kolluri A; Hummer AM; Torres MB; Zhu H; Hall MD; Luo X; Chen J; Wang Q; Abate-Daga D; Dropulic B; Hewitt SM; Orentas RJ; Greten TF; Ho M
Gastroenterology; 2020 Jun; 158(8):2250-2265.e20. PubMed ID: 32060001
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells.
Grunewald CM; Haist C; König C; Petzsch P; Bister A; Nößner E; Wiek C; Scheckenbach K; Köhrer K; Niegisch G; Hanenberg H; Hoffmann MJ
Front Immunol; 2021; 12():782448. PubMed ID: 34868059
[TBL] [Abstract][Full Text] [Related]
27. Chimeric Antigen Receptors for the Tumour Microenvironment.
Habib R; Nagrial A; Micklethwaite K; Gowrishankar K
Adv Exp Med Biol; 2020; 1263():117-143. PubMed ID: 32588326
[TBL] [Abstract][Full Text] [Related]
28. BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity.
Hickman TL; Choi E; Whiteman KR; Muralidharan S; Pai T; Johnson T; Parikh A; Friedman T; Gilbert M; Shen B; Barron L; McGinness KE; Ettenberg SA; Motz GT; Weiss GJ; Jensen-Smith A
PLoS One; 2022; 17(5):e0266980. PubMed ID: 35507536
[TBL] [Abstract][Full Text] [Related]
29. Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report.
Sun H; Xing C; Jiang S; Yu K; Dai S; Kong H; Jin Y; Shan Y; Yang W; Wang Z; Xiao J; Wang H; Wang W; Li Z; Shi K
Front Immunol; 2022; 13():963031. PubMed ID: 36059488
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated
Sui J; Zhao Q; Zhang Y; Liang G
DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
[TBL] [Abstract][Full Text] [Related]
31. Predictive and Prognostic Implications of Circulating CX3CR1
Abdelfatah E; Long MD; Kajihara R; Oba T; Yamauchi T; Chen H; Sarkar J; Attwood K; Matsuzaki J; Segal BH; Dy GK; Ito F
Cancer Res Commun; 2023 Mar; 3(3):510-520. PubMed ID: 37009132
[TBL] [Abstract][Full Text] [Related]
32. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery.
Shadbad MA; Asadzadeh Z; Derakhshani A; Hosseinkhani N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Brunetti O; Argentiero A; Racanelli V; Silvestris N; Baradaran B
Biomed Pharmacother; 2021 Nov; 143():112213. PubMed ID: 34560556
[TBL] [Abstract][Full Text] [Related]
33. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G
Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026
[TBL] [Abstract][Full Text] [Related]
34. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Yu T; Li J; Yan M; Liu L; Lin H; Zhao F; Sun L; Zhang Y; Cui Y; Zhang F; Li J; He X; Yao M
Oncogene; 2015 Jan; 34(4):413-23. PubMed ID: 24469061
[TBL] [Abstract][Full Text] [Related]
36. Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspective.
Mirzaei HR; Mirzaei H; Namdar A; Rahmati M; Till BG; Hadjati J
J Cell Physiol; 2019 May; 234(5):5827-5841. PubMed ID: 30317583
[TBL] [Abstract][Full Text] [Related]
37. Non-Coding RNAs in Human Breast Milk: A Systematic Review.
Tingö L; Ahlberg E; Johansson L; Pedersen SA; Chawla K; Sætrom P; Cione E; Simpson MR
Front Immunol; 2021; 12():725323. PubMed ID: 34539664
[TBL] [Abstract][Full Text] [Related]
38. Exosome miR-27a-3p secreted from adipocytes targets ICOS to promote antitumor immunity in lung adenocarcinoma.
Fan X; Wang J; Qin T; Zhang Y; Liu W; Jiang K; Huang D
Thorac Cancer; 2020 Jun; 11(6):1453-1464. PubMed ID: 32212417
[TBL] [Abstract][Full Text] [Related]
39. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
40. Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach.
Entezam M; Sanaei MJ; Mirzaei Y; Mer AH; Abdollahpour-Alitappeh M; Azadegan-Dehkordi F; Bagheri N
Life Sci; 2023 Apr; 318():121459. PubMed ID: 36720453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
